Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
33,454
Value
$90.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of FATE by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,454$90.3K<0.1%−1,868−5.3%ReducedHolders
Q1 202635,322$42.4K<0.1%+3,103+9.6%AddedHolders
Q4 202532,219$31.7K<0.1%−4,981−13.4%ReducedHolders
Q3 202537,200$46.9K<0.1%00.0%UnchangedHolders
Q2 202537,200$41.7K<0.1%+27,000+264.7%AddedHolders
Q1 202510,200$8.06K<0.1%00.0%UnchangedHolders
Q4 202410,200$16.8K<0.1%−400−3.8%ReducedHolders
Q3 202410,600$37.0K<0.1%−604−5.4%ReducedHolders
Q2 202411,204$37.0K<0.1%+104+0.9%AddedHolders
Q1 202411,100$81.0K<0.1%+200+1.8%AddedHolders
Q4 202310,900$40.0K<0.1%−5,071−31.8%ReducedHolders
Q3 202315,971$33.0K<0.1%−200−1.2%ReducedHolders
Q2 202316,171$78.0K<0.1%−485−2.9%ReducedHolders
Q1 202316,656$94.0K<0.1%+881+5.6%AddedHolders
Q4 202215,775$159.0K<0.1%−1,694−9.7%ReducedHolders
Q3 202217,469$391.0K<0.1%+7,019+67.2%AddedHolders
Q2 202210,450$261.0K<0.1%−7,911−43.1%ReducedHolders
Q1 202218,361$714.0K<0.1%+1,016+5.9%AddedHolders
Q4 202117,345$1.02M<0.1%+4,182+31.8%AddedHolders
Q3 202113,163$779.0K<0.1%−487−3.6%ReducedHolders
Q2 202113,650$1.19M<0.1%+7,098+108.3%AddedHolders
Q1 20216,552$540.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.